Search for: "Teva Pharmaceuticals"
Results 741 - 760
of 1,426
Sorted by Relevance
|
Sort by Date
24 Nov 2008, 3:28 pm
“Who do you think was the country's biggest supplier of prescription drugs in 2007? [read post]
11 May 2009, 9:03 am
In October 2005, Wyeth settled patent lawsuit for the same drug with Teva and as per agreement licensed Teva to launch a generic version in July 01, 2010 in return of certain percentage of profits from the generic sale. [read post]
3 Mar 2010, 5:05 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Cozaar (Losartan), Hyzaar (Hydrochlorothiazide; Losartan) – US: Teva prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva v Kathleen Sebelius (FDA Law Blog) (SmartBrief) Nexavar (Sorafenib) - India: More on Bayer patent linkage - Supreme Court admits special leave petition filed… [read post]
3 Mar 2010, 5:05 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Cozaar (Losartan), Hyzaar (Hydrochlorothiazide; Losartan) – US: Teva prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva v Kathleen Sebelius (FDA Law Blog) (SmartBrief) Nexavar (Sorafenib) - India: More on Bayer patent linkage - Supreme Court admits special leave petition filed… [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
8 Nov 2016, 11:53 pm
Among the generic drug companies experiencing this share price decline were Allergan, Teva Pharmaceuticals, and Endo Pharmaceuticals. [read post]
26 Aug 2009, 6:12 am
F. of L. files antitrust suit against Merck, alleging fraudulent procurement of a patent, improper listing of patent in Orange Book (Patent Docs) Singulair (Montelukast) – US: Merck get injunction preventing Teva from selling generic Montelukast: Merck Sharp & Dohme Pharmaceuticals SRL v Teva Pharmaceuticals USA (The IP Factor) (IP Watchdog) (SmartBrief) (SmartBrief) (GenericsWeb) [read post]
19 Jan 2010, 12:55 pm
Teva remains the most likely to go at-risk with 12 of the 28 at-risk launches since 2002. [read post]
13 Feb 2013, 11:49 pm
The invalidation was pursuant to a law suit bought by BMS (the patentee) against Teva, a leading Israeli generic company. [read post]
5 May 2010, 4:46 am
Cyclacel Pharmaceuticals Inc. [read post]
24 Aug 2022, 6:32 am
Teva Pharmaceuticals originally developed Elmiron, but it is now made and distributed by Janssen.Elmiron continues to be the only drug the U.S. [read post]
7 Mar 2008, 5:47 am
In August, Teva Pharmaceuticals USA submitted a Citizen Petition pursuant to section 505 of the Food, Drug, and Cosmetic Act (FDCA) asking the FDA to do just that. [read post]
24 Mar 2012, 1:20 pm
CAFC Rules “Secret Prior Art” Requires Only Appreciation that Invention Made in Teva Pharmaceutical*The doctrines of “secret prior art” and “inherency” both merged in the case Teva Pharmaceutical Industries Ltd. v. [read post]
18 Jun 2019, 8:59 pm
According to lawmakers, “Executives at Teva Pharmaceuticals allegedly orchestrated a sophisticated scheme to collude surreptitiously with competitors, artificially inflate the prices of over a hundred generic drugs, and destroy evidence of criminal conduct. [read post]
18 Jun 2019, 8:59 pm
According to lawmakers, “Executives at Teva Pharmaceuticals allegedly orchestrated a sophisticated scheme to collude surreptitiously with competitors, artificially inflate the prices of over a hundred generic drugs, and destroy evidence of criminal conduct. [read post]
11 Oct 2018, 12:57 am
As mentioned above, this decision came out before the CJEU’s judgment in C121/17 TEVA UK Ltd and others. [read post]
11 Feb 2007, 8:27 pm
Amphastar and Teva have filed ANDAs for generic Lovenox, and await FDA approval. [read post]
13 Jun 2011, 5:32 pm
(“APP”) and Sun Pharmaceuticals (“Sun”); however, all of these applicants submitted their applications subsequent to Teva’s ANDA submission. [read post]
3 Sep 2020, 5:03 am
Claims against Elmiron In March 2020, Teva Pharmaceuticals and Johnson & Johnson were delivered a lawsuit by Kimberly Pelczar. [read post]
26 Mar 2024, 7:01 pm
Late last week, the FTC submitted an Amicus Brief in recent Hatch-Waxman patent litigation in the District Court of New Jersey between Reference Listed Drug holder Teva Branded Pharmaceutical Products R&D Inc. and ANDA applicant Amneal Pharmaceuticals explaining that patents that claim the device constituent of a combination product but do not expressly claim the relevant drug substance should not be listed in the Orange Book. [read post]
